Ascletis Pharma Inc. (ASCLF)
USD 0.24
(0.0%)
USD 0.24
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 56.59 Million | 54.09 Million | 76.87 Million | 35 Million | 173.44 Million | 166.32 Million |
| Cost of Revenue | 30.6 Million | 78.78 Million | 37.7 Million | 58.49 Million | 49.16 Million | 12.37 Million |
| Gross Profit | 25.99 Million | -24.69 Million | 39.17 Million | -23.49 Million | 124.28 Million | 153.94 Million |
| Operating Expenses | 25.99 Million | 314.93 Million | 223.25 Million | 129.43 Million | 225.55 Million | 214.85 Million |
| Selling, General and Administrative Expenses | 62.96 Million | 32.41 Million | 37.36 Million | 47.79 Million | 125.04 Million | 144.42 Million |
| Research and Development Expenses | 216.78 Million | 267.1 Million | 213.32 Million | 109.09 Million | 125.96 Million | 143.45 Million |
| Other Expenses | - | -4.63 Million | -5000.00 | 59 Thousand | -369 Thousand | -10.75 Million |
| Cost and Expenses | 363.4 Million | 393.71 Million | 260.95 Million | 187.93 Million | 274.71 Million | 227.23 Million |
| Operating Income | - | -262.81 Million | -195.89 Million | -156.42 Million | -36.44 Million | -60.91 Million |
| Interest Expense | 144 Thousand | 157 Thousand | 125 Thousand | 135 Thousand | 182 Thousand | - |
| Income Tax Expense | - | 29.96 Million | 29.3 Million | 26.95 Million | 21.97 Million | -125 Thousand |
| Earnings before Tax | -144.71 Million | -314.84 Million | -199.01 Million | -209.24 Million | -95.96 Million | -19.87 Million |
| Net Income | -144.71 Million | -314.84 Million | -199.01 Million | -209.24 Million | -95.96 Million | -7.25 Million |
| Earnings Per Share Basic | -0.13 | -0.29 | -0.18 | -0.20 | -0.09 | -0.01 |
| Earnings Per Share Diluted | -0.13 | -0.29 | -0.18 | -0.20 | -0.09 | -0.01 |
| Weighted Average Shares Outstanding | 1.07 Billion | 1.08 Billion | 1.09 Billion | 1.04 Billion | 1.05 Billion | 869.04 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.07 Billion | 1.08 Billion | 1.09 Billion | 1.04 Billion | 1.05 Billion | 869.04 Million |
| Gross Margin | 0.46 | -0.46 | 0.51 | -0.67 | 0.72 | 0.93 |
| EBIT Margin | -2.23 | -4.30 | -2.16 | -3.69 | -0.08 | -0.29 |
| Profit Margin | -2.56 | -5.82 | -2.59 | -5.98 | -0.55 | -0.04 |
| EBITDA | -126.09 Million | -284.49 Million | -169.34 Million | -181.94 Million | -73.63 Million | -48.93 Million |
| Earnings Before Tax Margin | - | -4.86 | -2.55 | -4.47 | -0.21 | -0.37 |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 Q4 | 2022 FY | 2022 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.39 Million | 56.59 Million | 6.7 Million | 2.27 Million | 54.09 Million | 5.87 Million |
| Cost of Revenue | 3.89 Million | 30.6 Million | 1.91 Million | 11.07 Million | 78.78 Million | 4.17 Million |
| Gross Profit | -2.5 Million | 25.99 Million | 4.79 Million | -8.79 Million | -24.69 Million | 1.7 Million |
| Operating Expenses | 28.82 Million | 326.19 Million | 16.38 Million | 22.95 Million | 314.93 Million | 20.6 Million |
| Selling, General and Administrative Expenses | 12.35 Million | - | 3.85 Million | 3.41 Million | - | 4.37 Million |
| Research and Development Expenses | 16.46 Million | - | 12.53 Million | 19.54 Million | - | 16.23 Million |
| Other Expenses | - | -2.03 Million | - | - | -4.63 Million | - |
| Cost and Expenses | 32.72 Million | 356.8 Million | 18.29 Million | 34.03 Million | 393.71 Million | 24.78 Million |
| Operating Income | -31.32 Million | -308.94 Million | -11.58 Million | -31.75 Million | -262.81 Million | -18.9 Million |
| Interest Expense | 10.23 Thousand | 144 Thousand | 10.09 Thousand | 14.36 Thousand | 157 Thousand | 8768.83 |
| Income Tax Expense | 1.32 Million | 95.4 Million | 1.54 Million | 1.72 Million | 29.96 Million | 1.67 Million |
| Earnings before Tax | -16.4 Million | -144.71 Million | -845.59 Thousand | -30.85 Million | -314.84 Million | -11.86 Million |
| Net Income | -17.72 Million | -144.71 Million | -2.38 Million | -32.58 Million | -314.84 Million | -13.53 Million |
| Earnings Per Share Basic | -0.02 | - | -0.00 | -0.03 | - | -0.01 |
| Earnings Per Share Diluted | -0.02 | - | -0.00 | -0.03 | - | -0.01 |
| Weighted Average Shares Outstanding | 1.04 Billion | 1.07 Billion | 1.08 Billion | 1.08 Billion | 1.08 Billion | 1.08 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.04 Billion | 1.07 Billion | 1.08 Billion | 1.08 Billion | 1.08 Billion | 1.08 Billion |
| Gross Margin | -1.79 | 0.46 | 0.71 | -3.86 | -0.46 | 0.29 |
| EBIT Margin | -21.47 | - | -1.54 | -12.96 | - | -2.82 |
| Profit Margin | -12.70 | -2.56 | -0.36 | -14.29 | -5.82 | -2.30 |
| EBITDA | -29.96 Million | - | -10.3 Million | -29.53 Million | - | -16.58 Million |
| Earnings Before Tax Margin | -22.45 | -5.46 | -1.73 | -13.93 | -4.86 | -3.22 |
BKHPF
7031
3988
CVONF
VNRFY
002895